Familial hypercholesterolemia: Diagnosis and management10' education - Apr. 10, 2018 - Prof. Frederick Raal - University of the Witwatersrand, Johannesburg, South Africa
Prof. Frederick Raal describes the prevalence and phenotypic variability of FH. Novel therapies have changed FH from a lethal disorder to a manageable dyslipidaemia.
Video navigation menu
- Phenotypic variability in FH 00:54
- Current/emerging therapies for severe FH 01:49
- LDL-c reduction with PCSK9 inhibitors in HeFH/HoFH 02:29
- Future perspectives for severe HoFH 04:03
Professor Frederick Raal is Professor and Head of the Division of Endocrinology and Metabolism at the University of the Witwatersrand, Johannesburg.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme. PACE-cme did not receive financial support for the production of this recording.